The Great Debate 2019 - Q&A Session

Session
Wednesday, 13 March 2019
20:13 - 20:13
Duration: 51 mins
Publication date: 18 Mar 2019
Location: Conference, University of Reading
Part of series The Great Debate and Part of event The Great debate 2019

About the session

The increasing adoption of digital technology has resulted in fundamental changes in many industries. Yet healthcare, which represents about 10% of global GDP, has lagged other sectors. This is about to change as big data and artificial intelligence will deliver improvements in diagnosis and treatment that will increase health care's reach, efficiency, accuracy and reduce waiting time for patients.

Technological advances offer significant opportunities to improve healthcare and have the potential to deliver significant value for the NHS. This year's Great Debate will provide an update on the latest technology advances to deliver these benefits.

Channels

Communities

Health care

Speakers

Professor Rachel McCrindle

University of Reading, Professor of Computer & Human Interaction

Rachel McCrindle is Professor of Computer and Human Interaction in the Biomedical Engineering Section of the School of Biological Sciences at the University of Reading where she is co-leading a multidisciplinary team developing exergames for rehabilitation of stroke/brain injury patients in hospital and at home, in a collaboration that involves academics across several disciplines, NHS staff, patients, carers and a commercial company. This product is now being transitioned into the clinical environment. Other current work is investigating how digital technologies can be used to enhance participation in social and leisure activities for individuals with acquired brain injury. Her work places emphasis on ensuring that users are placed at the centre of the development process in order that the systems developed are accessible, engaging and personalised to individuals’ needs. Rachel also has particular interest in Knowledge Transfer Partnerships between SMEs and the University for which she has won a number of national awards, and in working jointly with colleagues in the NHS and highlights the value that these collaborations can bring to all parties. Rachel has a BSc in Biology from the University of Liverpool, an MSc with Distinction in IT and Manufacturing Systems from the University of Warwick, and a PhD in Computer Science from the University of Durham
Dr Helen Meese

The Care Machine Ltd, Managing Director

Helen is an Electro-Mechanical Power Engineer with over 20 years’ experience in both academia and industry. Helen studied for her PhD at Loughborough University. She spent many years in the defence industry before joining the IMechE in 2013 as Head of Engineering in Society. She became Head of Healthcare in 2015, managing its programme on medical technology and infrastructure across all aspects of health and social care; focusing on impact to UK and global communities. Helen has appeared on TV and radio as well as writing numerous reports, policy statements and articles on health-related matters. Now as Managing Director of The Care Machine, Helen continues to deliver thought leadership across the medtech sector, championing the impact of biomedical, pharmaceutical and mechanical engineering in medicine. She is also a Trustee of the IMechE.
Dr Lawrence Petalidis

Chelsea and Westminster NHS Health Charity, Head of Innovation and Impact

Lawrence led the development of an innovation hub at Chelsea and Westminster NHS over the last 3 years securing and funding some 20 digital health projects and collaborations including a multimillion clinical AI analytics agreement. Lawrence is a HIMSSGlobal speaker, has served as a NHS Navigator for the Digital Health.London Accelerator and advises digital health start-ups on commercial and evidence strategy. He is passionate about clinical frontlines, innovation operations, change and bridging the gaps between health, tech, academia and business. Lawrence has a PhD in molecular neuro-oncology from Addenbrookes Hospital, University of Cambridge and some 14 years of experience across business, commercial, knowledge transfer, digital change and health innovation roles.
Dr Richard Dybowski

University of Cambridge

Richard is a mathematician, statistician and computer scientist in the Disease Dynamic Unit at University of Cambridge. Following a degree in Chemistry he undertook a PhD in statistical and computational chemistry (the computational chemistry of endocrine metabolites) and then undertook statistical research into a variety of medical areas, including microbiology, intensive care and ophthalmology at St Thomas’ Hospital/King’s College London. He has also taught artificial intelligence (AI) at the University of East London.His research interests at Cambridge University lie within the areas of (a) stochastic models of biomedical phenomena, (b) machine learning (particularly deep learning), and (c) normative clinical reasoning.
Professor Stuart Green

Chairman: Professor Stuart Green, University of ReadingProfessor Stuart Green is Professor of Construction Management in the School of the Built Environment at the University of Reading.He originally studied civil engineering at the University of Birmingham, graduating in 1979. For several years thereafter he worked in industry gaining design experience with an international engineering consultancy. He completed his PhD in 1996 and was appointed professor in 2002. Stuart has extensive experience of research leadership and has been Principal Investigator on Engineering and Physical Sciences Research Council (EPSRC) research awards totalling in excess of £7 million. He is a chartered civil engineer.
Dr Lawrence Petalidis

Chelsea and Westminster NHS Health Charity, Head of Innovation and Impact

Lawrence led the development of an innovation hub at Chelsea and Westminster NHS over the last 3 years securing and funding some 20 digital health projects and collaborations including a multimillion clinical AI analytics agreement. Lawrence is a HIMSSGlobal speaker, has served as a NHS Navigator for the Digital Health.London Accelerator and advises digital health start-ups on commercial and evidence strategy. He is passionate about clinical frontlines, innovation operations, change and bridging the gaps between health, tech, academia and business. Lawrence has a PhD in molecular neuro-oncology from Addenbrookes Hospital, University of Cambridge and some 14 years of experience across business, commercial, knowledge transfer, digital change and health innovation roles.

About the session

Channels

Title